Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

Taiwan · Delayed Price · Currency is TWD

140.00

-1.00 (-0.71%)

Apr 17, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Cell Preparations	773.25M	783.90M	615.71M	491.26M	353.63M
Cell Preparations Growth	-1.36%	27.31%	25.33%	38.92%	400.91%
Other	244.25M	151.11M	143.59M	137.70M	48.20M
Other Growth	61.64%	5.24%	4.28%	185.66%	-
Adjustment and Elimination	-	-1.19M	-910.00K	-1.45M	-187.00K
Total	1.02B	933.81M	758.39M	627.51M	401.64M
Total Growth	8.96%	23.13%	20.86%	56.24%	468.92%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	1.02B	933.81M	758.39M	627.51M	438.84M
Taiwan Growth	8.96%	23.13%	20.86%	42.99%	521.61%
Total	1.02B	933.81M	758.39M	627.51M	438.84M
Total Growth	8.96%	23.13%	20.86%	42.99%	521.61%

Source: S&P Global Market Intelligence.